Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Rigo

Showing results (51-60 of 163) with videos related to

Pageof 17
Sort By:
Human Gene Therapy|July 7, 2022
Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 1Siham Ait Benichou, Dominic Jauvin, Thiéry De Serres-Bérard, et al.
Science Translational Medicine|July 29, 2021
Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALSAlyssa N Coyne, Victoria Baskerville, Benjamin L Zaepfel, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2015
Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II/III spinal muscular atrophyLaurent P Bogdanik, Melissa A Osborne, Crystal Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2023
The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cellsXinyuan Chen, Harry Taegyun Yang, Beatrice Zhang, et al.
Plos One|March 9, 2023
Targeting nonsense-mediated RNA decay does not increase progranulin levels in the Grn R493X mouse model of frontotemporal dementiaDenise M Smith, Michael L Niehoff, Karen Ling, et al.
Human Molecular Genetics|April 21, 2020
ALS-associated genes in SCA2 mouse spinal cord transcriptomesDaniel R Scoles, Warunee Dansithong, Lance T Pflieger, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 2, 2023
Carbogen-Induced Respiratory Acidosis Blocks Experimental Seizures by a Direct and Specific Inhibition of Na<sub>V</sub>1.2 Channels in the Axon Initial Segment of Pyramidal NeuronsRobert J Hatch, Géza Berecki, Nikola Jancovski, et al.
JCI Insight|May 17, 2019
An endogenous peptide marker differentiates SOD1 stability and facilitates pharmacodynamic monitoring in SOD1 amyotrophic lateral sclerosisIlya Gertsman, Joanne Wuu, Melissa McAlonis-Downes, et al.
Acta Neuropathologica|November 29, 2023
G<sub>2</sub>C<sub>4</sub> targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neuronsJeffrey D Rothstein, Victoria Baskerville, Sampath Rapuri, et al.
Journal of Medicinal Chemistry|July 18, 2020
Targeted Delivery of Antisense Oligonucleotides Using Neurotensin PeptidesMehran Nikan, Michael Tanowitz, Chrissa A Dwyer, et al.
Pageof 17

Showing results (51-60 of 163) with videos related to

Sort By:
Pageof 17
Human Gene Therapy|July 7, 2022
Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 1Siham Ait Benichou, Dominic Jauvin, Thiéry De Serres-Bérard, et al.
Science Translational Medicine|July 29, 2021
Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALSAlyssa N Coyne, Victoria Baskerville, Benjamin L Zaepfel, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2015
Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II/III spinal muscular atrophyLaurent P Bogdanik, Melissa A Osborne, Crystal Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2023
The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cellsXinyuan Chen, Harry Taegyun Yang, Beatrice Zhang, et al.
Plos One|March 9, 2023
Targeting nonsense-mediated RNA decay does not increase progranulin levels in the Grn R493X mouse model of frontotemporal dementiaDenise M Smith, Michael L Niehoff, Karen Ling, et al.
Human Molecular Genetics|April 21, 2020
ALS-associated genes in SCA2 mouse spinal cord transcriptomesDaniel R Scoles, Warunee Dansithong, Lance T Pflieger, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 2, 2023
Carbogen-Induced Respiratory Acidosis Blocks Experimental Seizures by a Direct and Specific Inhibition of Na<sub>V</sub>1.2 Channels in the Axon Initial Segment of Pyramidal NeuronsRobert J Hatch, Géza Berecki, Nikola Jancovski, et al.
JCI Insight|May 17, 2019
An endogenous peptide marker differentiates SOD1 stability and facilitates pharmacodynamic monitoring in SOD1 amyotrophic lateral sclerosisIlya Gertsman, Joanne Wuu, Melissa McAlonis-Downes, et al.
Acta Neuropathologica|November 29, 2023
G<sub>2</sub>C<sub>4</sub> targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neuronsJeffrey D Rothstein, Victoria Baskerville, Sampath Rapuri, et al.
Journal of Medicinal Chemistry|July 18, 2020
Targeted Delivery of Antisense Oligonucleotides Using Neurotensin PeptidesMehran Nikan, Michael Tanowitz, Chrissa A Dwyer, et al.
Pageof 17